페이마시스 (FEMY) 주가

페이마시스(FEMY)는 NASDAQ에 상장된 Healthcare · Medical Instruments & Supplies 기업입니다. 현재가 $2.59 (+1.57%), 시가총액 $0.02B, 52주 최저~최고 $0.34 ~ $1.08.

Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual balloon catheter for selective tube evaluation. It also provides FemBloc, a non-surgical female permanent birth control solution. The company offers its products to gynecological physicians, related he

핵심 지표

• 현재가: $2.59 (+1.57%)
• 시가총액: $0.02B
• 52주 최저~최고: $0.34 ~ $1.08
• 섹터: Healthcare
• 산업: Medical Instruments & Supplies
• 거래소: NASDAQ

페이마시스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.

페이마시스 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 4.5

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 4.38
• 순이익률: 0.00%
• 영업이익률: -5.68%

자주 묻는 질문